General Information of This Antibody-drug Conjugate (ID: DRG0IMHRJ)
ADC Name
QLS5132
Synonyms
QLS5132
   Click to Show/Hide
Organization
Qilu Pharmaceutical (Originator)
Drug Status
Phase 1/2
Antibody Name
Anti-CLDN6 antibody
 Antibody Info 
Antigen Name
Claudin-6 (CLDN6)
 Antigen Info 
Payload Name
QLS6916
 Payload Info 
Payload Target
Human deoxyribonucleic acid (hDNA)
 Target Info 
Linker Name
A cleavable linker
 Linker Info 
Conjugate Type
Undisclosed
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
Disease Name Phase 1 Phase 2 Phase 3 Approved
Unspecific solid tumor
1 Trials
Clinical trial identifier
NCT06932094; CTR20251836